Searching the RRID Resource Information Network
Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
SciCrunch Registry is a curated repository of scientific resources, with a focus on biomedical resources, including tools, databases, and core facilities - visit SciCrunch to register your resource.
| Resource Name | Proper Citation | Abbreviations | Resource Type |
Description |
Keywords | Resource Relationships | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Pipeliner Resource Report Resource Website 1+ mentions |
Pipeliner (RRID:SCR_003171) | software resource | Software for evaluating the performance of bioinformatics pipelines for Next Generation re-Sequencing. | standalone software, c++, bio.tools |
is listed by: OMICtools is listed by: bio.tools is listed by: Debian |
PMID:24890372 | Free, Available for download, Freely available | OMICS_04844, biotools:pipeliner | https://bio.tools/pipeliner | SCR_003171 | 2026-07-25 12:05:37 | 6 | |||||||
|
Allele Biotechnology Resource Report Resource Website 1+ mentions |
Allele Biotechnology (RRID:SCR_003164) | Allele Biotech | commercial organization | A private company offering a wide variety of Molecular Biology reagents, fluorescent proteins, luciferase assay substrates, genotyping kits, and various custom services. The company isalso in the RNAi field with its recent patents in Pol III promoter-driven siRNA, shRNA, and miRNA. They introduced high titer lentivirus, camelid antibodies, and cell based assays and also offer Baculovirus protein expression and Gryphon retrovirus systems. | molecular biology, reagent, fluorescent protein, luciferase assay substrate, genotyping kit, custom service | is related to: Phoenix | Free, Available for download, Freely available | nlx_156865 | SCR_003164 | Allele Biotechnology and Pharmaceuticals Inc | 2026-07-25 12:05:38 | 1 | |||||||
|
American Association for the History of Medicine Resource Report Resource Website |
American Association for the History of Medicine (RRID:SCR_003161) | AAHM | nonprofit organization | A professional association of historians, physicians, nurses, archivists, curators, librarians, and others that promotes and encourages research, study, writing, and interest in the history of medicine and allied fields. | history, medicine | Free, Freely available | nlx_156861, grid.486311.9 | https://ror.org/04w1hax42 | SCR_003161 | 2026-07-25 12:05:37 | 0 | ||||||||
|
Relypsa Resource Report Resource Website |
Relypsa (RRID:SCR_004047) | RLYP | commercial organization | Biopharmaceutical company focused on development and commercialization of non-absorbed polymeric drugs to treat disorders in areas of renal, cardiovascular and metabolic diseases.February 2021 - Relypsa changed its name to Vifor Pharma. Company is focused on development and commercialization of late stage medicines that will change treatment paradigms and improve patients lives. | biopharmaceutical, pharmaceutical, drug, late stage medicines, late stage medicines commercialization, late stage medicines development | is related to: Kidney Health Initiative | nlx_158475 | SCR_004047 | Relypsa Inc., Vifor Pharma | 2026-07-25 12:05:46 | 0 | ||||||||
|
CADRO Resource Report Resource Website 1+ mentions |
CADRO (RRID:SCR_004046) | CADRO | controlled vocabulary, data or information resource | A classification system developed by the National Institute on Aging and the Alzheimer's Association that can be used to integrate and compare Alzheimer's disease (AD) research portfolios from public and private organizations supporting AD research in the US and abroad. The CADRO was constructed as a three-tier classification system organized around seven major categories: five in research and two resource-related: * Category A. Molecular Pathogenesis and Pathophysiology of Alzheimer's Disease * Category B. Diagnosis, Assessment and Disease Monitoring * Category C. Translational Research and Clinical Interventions * Category D. Epidemiology * Category E. Care, Support and Health Economics of Alzheimer's Diseases * Category F. Research Resources * Category G. Consortia and Public Private Partnerships * Category H. Alzheimer's Disease - Related Dementias Using information from project abstracts and research aims, the above categories were stratified into research topics and these were further divided into research themes. The three levels of classification are meant to enable a fine-grained portfolio analysis that can inform strategic planning and funding decisions. The CADRO was developed as a dynamic portfolio analysis tool that can be used to: (i) capture the changing landscape of AD research funded by different organizations, (ii) identify opportunities for coordination of support for AD research, and (iii) identify funding gaps as well as areas of overlap within and across organizations. | late adult human, alzheimer, aging |
is used by: IADRP has parent organization: Alzheimers Association has parent organization: National Institute on Aging |
Alzheimer's disease, Aging | NIA | nlx_158474 | http://www.nia.nih.gov/research/dn/cadro-outline, http://www.nia.nih.gov/research/dn/common-alzheimers-disease-research-ontology-cadro, http://www.nia.nih.gov/sites/default/files/cadro_outline_-_january_2013.pdf | SCR_004046 | Common Alzheimer''s Disease Research Ontology, Common Alzheimer's Disease Research Ontology (CADRO) | 2026-07-25 12:05:45 | 2 | |||||
|
Reata Pharmaceuticals Resource Report Resource Website 1+ mentions |
Reata Pharmaceuticals (RRID:SCR_004040) | Reata | commercial organization | Pharmaceutical company focused on investigating experimental oral antioxidative and anti-inflammatory drugs, which dually activate the antioxidative transcription factor Nrf2 (Nuclear factor (erythroid-derived 2)-like 2) and inhibit the pro-inflammatory transcription factor NF-B (nuclear factor kappa-light-chain-enhancer of activated B cells). The antioxidative and anti-inflammatory compounds bardoxolone methyl and RTA 408 are the lead clinical development compounds in their portfolio. | pharmaceutical, drug, immuno-oncology, ophthalmology, cardiovascular, autoimmune, respiratory, antioxidant inflammation modulator, oxidative stress, medicine, dermatology, skin, eye, clinical trial, nrf2, nf-b, bardoxolone methyl, rta 408, transcription, dna, transcription factor | is related to: Kidney Health Initiative | nlx_158468 | SCR_004040 | Reata Pharmaceuticals Inc. | 2026-07-25 12:05:46 | 2 | ||||||||
|
Otsuka America Pharmaceutical Inc. Resource Report Resource Website 1+ mentions |
Otsuka America Pharmaceutical Inc. (RRID:SCR_004036) | OAPI | commercial organization | Healthcare company that oversees all pharmaceutical and medical device commercial activities of Otsuka Group (Otsuka) in North America. Products with emphasis on neuroscience, oncology, cardio-renal, and medical device markets. | pharmaceutical, medical device, neuroscience, oncology, cardio-renal, commercial | is related to: Kidney Health Initiative | nlx_158462 | http://www.otsuka-us.com/Companies/OAPI/ | SCR_004036 | Otsuka America Pharmaceutical | 2026-07-25 12:05:45 | 1 | |||||||
|
Proteon Therapeutics Resource Report Resource Website 1+ mentions |
Proteon Therapeutics (RRID:SCR_004037) | Proteon | commercial organization | A biopharmaceutical company developing pharmaceuticals for patients with renal and vascular diseases. Their ongoing Phase 3 clinical trial is evaluating whether a single treatment of PRT-201 can reduce vascular access failure, one of the most serious problems experienced by patients with chronic kidney disease (CKD) undergoing hemodialysis. PRT-201 is an investigational drug that may inhibit neointimal hyperplasia, the growth of tissue inside blood vessels that can result in vessel narrowing and reduced blood flow. PRT-201 has received fast track and orphan drug designations for hemodialysis vascular access indications.In September 2019, Proteon Therapeutics merged with ArTara Therapeutics. | biopharmaceutical, pharmaceutical, hemodialysis, prt-201, drug |
is related to: Kidney Health Initiative is related to: Protara Therapeutics |
Kidney disease, Vascular disease, Chronic kidney disease, Neointimal hyperplasia, Peripheral arterial disease | nlx_158465 | SCR_004037 | Proteon Therapeutics Inc. | 2026-07-25 12:05:46 | 1 | |||||||
|
Multiple Sclerosis Society Resource Report Resource Website 10+ mentions |
Multiple Sclerosis Society (RRID:SCR_004153) | MS Society | nonprofit organization | The UK''s leading MS charity that provides information and support, funding research and fighting for change. We''re a democratic organization: one member, one vote. We fund research, give grants, campaign for change, provide information and support, invest in MS specialists and lend a listening ear to those who need it. The UK''s biggest MS charity. * 38,000 members have a say in how we''re run. * 9000 volunteers give a million hours every year. * 550 staff work in all four nations of the UK. * Over 300 branches support people with MS locally. * One aim: to beat MS. Our national offices in England, Scotland, Wales and Northern Ireland and our network of 300 branches support people affected by MS locally. | Crossref funder ID: 501100000381, ISNI: 0000 0001 0665 6519, nlx_143577, Wikidata: Q6934907, grid.453295.c | https://ror.org/043fwdk81 | SCR_004153 | 2026-07-25 12:05:47 | 18 | ||||||||||
|
Endocells Resource Report Resource Website 10+ mentions |
Endocells (RRID:SCR_004067) | Endocells | commercial organization | This resource no longer in service. Documented on August 12, 2021. French biotech company dedicated to human endocrine cell line production with a first focus on human pancreatic beta cell. Other cell types are being prepared like glucagon cells. The material will be powerful tools for drug discovery, toxicology and cell replacement therapy. Achievements to date * Generated tumoral and non-tumoral human beta cell lines which closely resemble human primary pancreatic beta cells (using technologies which have been first developed and validated using immortalized rat beta cell lines). World first. * Established a robust technology platform which will be used to develop other human endocrine cell lines. | pancreas, endocrine system, replacement cell therapy, glucagon, drug discovery, toxicology, pancreatic beta cell, cell line, human endocrine cell line, beta cell, glucagon cell, tumor |
is listed by: One Mind Biospecimen Bank Listing is related to: IMIDIA |
nlx_158504 | SCR_004067 | Endocells SARL, SARL Endocells | 2026-07-25 12:05:48 | 15 | ||||||||
|
Genomedics Resource Report Resource Website |
Genomedics (RRID:SCR_004103) | Genomedics | commercial organization | A commercial company specialized in the field of clinical governance, research and clinical-epidemiological analysis and development of services and software applications for healthcare. Products and Services * Analysis and development software solutions, web, e-learning * Design and Implementation APP for Smartphone and Tablet (iOS, Android, Windows Phone) * Clinical Intelligence & Clinical Decision Support Systems (CDSS) * Data center services and Application Server Provider * Epidemiology, Surveillance and Health Promotion - Development of studies and epidemiological research | healthcare, clinical, medicine, health, information service, analysis, software development, web portal, multimedia, e-learning, data center service, application server, business intelligence, epidemiology, surveillance, health promotion, population | is related to: EMIF | nlx_158578 | SCR_004103 | Genomedics health care consultants, Genomedics S.r.l. | 2026-07-25 12:05:47 | 0 | ||||||||
|
European ScreeningPort Resource Report Resource Website |
European ScreeningPort (RRID:SCR_004061) | ESP | commercial organization | Commercial organization that aims to bridge the gap between academia and the life-sciences industry with a wide ranging experience in pharmaceutical industry R&D covering multiple target classes and therapeutic areas. This deep scientific insight and established links with world class research institutions is applied across their business groups: * Drug Discovery * Biomarker and Translational Research * Enabling Technologies * R&D Information Technologies They measure their performance by successful outcomes for their collaborators, and recognize that an authentic partnership approach is essential in achieving the goal of converting outstanding science into high quality starting points for new medicines. | pharmaceutical |
is related to: Kinetics for Drug Discovery has parent organization: Mainz Institute of Molecular Biology Bioinformatics Core Facility |
German Federal Ministry of Education and Research ; Norgenta |
nlx_158497 | SCR_004061 | European Screening Port, European Screening Port GmbH, European ScreeningPort GmbH | 2026-07-25 12:05:48 | 0 | |||||||
|
W. L. Gore and Associates Resource Report Resource Website 1+ mentions |
W. L. Gore and Associates (RRID:SCR_004060) | Gore | commercial organization | An American manufacturing company specializing in products derived from fluoropolymers that focuses its efforts in four main areas: electronics, fabrics, industrial and medical products. | medical device, implant, copper, optical, signal transmission, electronic, fabric, industrial product, medical product, contamination | is related to: Kidney Health Initiative | nlx_158494 | SCR_004060 | W. L. Gore & Associates Inc., W.L. Gore & Associates Inc., W.L. Gore and Associates, W. L. Gore & Associates, W.L. Gore & Associates | 2026-07-25 12:05:46 | 1 | ||||||||
|
Sierra Sensors Resource Report Resource Website 1+ mentions |
Sierra Sensors (RRID:SCR_004062) | commercial organization | In 2018 Bruker acquired Sierra Sensors GmbH, based in Hamburg, Germany. Sierra develops and manufactures innovative analytical biosensors based on Surface Plasmon Resonance (SPR) detection. Driven by patented technologies in the areas of SPR detection and microfluidic sample delivery, Sierra instruments are setting a new standard in high-throughput and high-performance label-free analysis. | biosensor, analytical tool, molecule, interaction, label-free analysis, analysis, assay, microfluidic, diagnostic | is related to: Kinetics for Drug Discovery | nlx_158499 | SCR_004062 | Sierra Sensors Biosensor Technologies, Sierra Sensors GmbH | 2026-07-25 12:05:46 | 1 | |||||||||
|
National Cancer Research Institute Resource Report Resource Website 1+ mentions |
National Cancer Research Institute (RRID:SCR_004057) | NCRI | institution | The National Cancer Research Institute (NCRI) is a UK-wide partnership between the government, charity and industry which promotes co-operation in cancer research among the 22 member organizations for the benefit of patients, the public and the scientific community. Cancer affects everyone. One third of people in the UK get cancer at some time in their lives and a quarter of all people die from it. This means that even if we don''t have cancer ourselves, we know someone who does, or soon will. | is parent organization of: onCore UK | Crossref funder ID: 100008667, Wikidata: Q6971241, ISNI: 0000 0004 0578 6831, grid.451262.6, nlx_143544 | https://ror.org/02mp0vf47 | http://www.ncri.org.uk/default.asp | SCR_004057 | NCRI - National Cancer Research Institute | 2026-07-25 12:05:46 | 1 | |||||||
|
Vasculitis Foundation Resource Report Resource Website |
Vasculitis Foundation (RRID:SCR_004059) | VF | institution | An international organization for patients with vasculitis, their families, friends and the health care professionals who care for them, supporting and empowering them through education, awareness and research. The Foundation advocates for early diagnosis and leading edge treatment for all. The Foundation also partners with researchers around the world to determine the cause and discover the cure for vasculitis. | clinical, pediatric, child, funding resource | is related to: Kidney Health Initiative | Vasculitis | Crossref funder ID: 100007211, grid.453926.f, nlx_158493 | https://ror.org/03f9wqe45 | SCR_004059 | 2026-07-25 12:05:46 | 0 | |||||||
|
Boston University; Massachusetts; USA Resource Report Resource Website 1+ mentions |
Boston University; Massachusetts; USA (RRID:SCR_004054) | BU | university | Private research university in Boston, Massachusetts. The university is nonsectarian but maintains its historical affiliation with the United Methodist Church. It was founded in 1839 by Methodists with its original campus in Newbury, Vermont, before moving to Boston in 1867. |
uses: ResearchConnection is used by: ResearchConnection is related to: Alzheimers Disease Genetics Consortium is related to: International AMD Genetics Consortium is related to: Clinical and Translational Science Awards Consortium is related to: Piirus is parent organization of: EarLab is parent organization of: Evolutionary Lineage Inferred from Structural Analysis is parent organization of: Speech Language Disorders Database is parent organization of: Boston University Medical Campus; Massachusetts; USA is parent organization of: StellaBase: Nematostella vactensis genomics database is parent organization of: Tandem Repeats Database is parent organization of: Yeast Mitochondrial Protein Database is parent organization of: Boston University Department of Neuroscience is parent organization of: Many Microbe Microarrays Database is parent organization of: PRECISE is parent organization of: SIEGE- Smoking Induced Epithelial Gene Expression is parent organization of: Visionary: A Dictionary for the Study of Vision is parent organization of: Framingham Heart Study is parent organization of: Boston University School of Medicine; Massachusetts; USA is parent organization of: Boston University Labs and Facilities is parent organization of: Boston University Microarray Resource Core is parent organization of: CnidBase is parent organization of: OBART is parent organization of: Graph Theory GLM (GTG) MATLAB Toolbox is parent organization of: ClusPro is parent organization of: openEyeTrack project is parent organization of: Boston University Microarray and Sequencing Resource Core Facility is parent organization of: Teensy-Based Interface project |
Crossref funder ID:100007161, grid.189504.1, ISNI:0000 0004 1936 7558, nlx_75713, Wikidata:Q49110 | https://ror.org/05qwgg493 | SCR_004054 | Boston University | 2026-07-25 12:05:48 | 6 | ||||||||
|
University of Lodz; Lodz; Poland Resource Report Resource Website |
University of Lodz; Lodz; Poland (RRID:SCR_004053) | university | Public research university founded in 1945 in Łódź, Poland, as a continuation of educational institutions functioning in Łódź in the interwar period — the Teacher Training Institute, the Higher School of Social and Economic Sciences and a division of the Free Polish University. |
is related to: AddNeuroMed is related to: EARIP |
ISNI:0000 0000 9730 2769, grid.10789.37, nlx_158123, Crossref funder ID:501100005643, Wikidata:Q137503 | https://ror.org/05cq64r17 | SCR_004053 | Uniwersytet �dzki, University of �d, University of Lodz | 2026-07-25 12:05:46 | 0 | |||||||||
|
Thrasos Therapeutics Resource Report Resource Website |
Thrasos Therapeutics (RRID:SCR_004052) | Thrasos | commercial organization | Private, clinical stage biotherapeutics company focused on delivering new solutions to individuals affected by kidney disease. They are committed to developing novel approaches to protect, treat and restore kidney function for this patient group. Company has designed specific class of peptide compounds that have shown excellent results in controlling experimental kidney diseases, notably, models of diabetic nephropathy (kidney damage associated with diabetes), and acute kidney injury. These proprietary peptides may therefore be able to prevent and treat acute kidney injury, as well as slow and possibly reverse the progression of diabetic nephropathy. They act to control apoptosis (programmed cell death), inflammation and fibrosis (formation of scar tissue). | Controlling experimental kidney diseases, biotherapeutics, clinical, peptide, treat acute kidney injury, reverse progression diabetic nephropathy | is related to: Kidney Health Initiative | Kidney disease, Acute kidney injury, Diabetic nephropathy, Chronic kidney disease | nlx_158489 | http://www.thrasos.com/ | SCR_004052 | Thrasos Innovation Inc. | 2026-07-25 12:05:46 | 0 | ||||||
|
American Psychological Association Resource Report Resource Website 1000+ mentions |
American Psychological Association (RRID:SCR_004083) | APA | professional organization | Based in Washington, D.C., the American Psychological Association (APA) is a scientific and professional organization that represents psychology in the United States. With more than 154,000 members, APA is the largest association of psychologists worldwide. The mission of the APA is to advance the creation, communication and application of psychological knowledge to benefit society and improve people''s lives. The American Psychological Association aspires to excel as a valuable, effective and influential organization advancing psychology as a science, serving as: * A uniting force for the discipline * The major catalyst for the stimulation, growth and dissemination of psychological science and practice * The primary resource for all psychologists * The premier innovator in the education, development, and training of psychological scientists, practitioners and educators * The leading advocate for psychological knowledge and practice informing policy makers and the public to improve public policy and daily living * A principal leader and global partner promoting psychological knowledge and methods to facilitate the resolution of personal, societal and global challenges in diverse, multicultural and international contexts * An effective champion of the application of psychology to promote human rights, health, well being and dignity APA and its affiliate organizations provide a diverse range of scholarships, grants, and awards with the aim of advancing research in psychology. Using our specialized search tool, you can find funding by type, sponsor, topic area, recipient type, and deadline date. | is parent organization of: PsycINFO | Crossref funder ID: 100006324, Wikidata: Q466587, nlx_143547, grid.280937.7, ISNI: 0000 0001 2166 7523 | https://ror.org/00rt1d436 | SCR_004083 | 2026-07-25 12:05:46 | 1763 |
Can't find your Tool?
We recommend that you click next to the search bar to check some helpful tips on searches and refine your search firstly. Alternatively, please register your tool with the SciCrunch Registry by adding a little information to a web form, logging in will enable users to create a provisional RRID, but it not required to submit.
Welcome to the SPARC SAWG Resources search. From here you can search through a compilation of resources used by SPARC SAWG and see how data is organized within our community.
You are currently on the Community Resources tab looking through categories and sources that SPARC SAWG has compiled. You can navigate through those categories from here or change to a different tab to execute your search through. Each tab gives a different perspective on data.
If you have an account on SPARC SAWG then you can log in from here to get additional features in SPARC SAWG such as Collections, Saved Searches, and managing Resources.
Here is the search term that is being executed, you can type in anything you want to search for. Some tips to help searching:
If you are logged into SPARC SAWG you can add data records to your collections to create custom spreadsheets across multiple sources of data.
Here are the facets that you can filter the data by.
If you have any further questions please check out our FAQs Page to ask questions and see our tutorials. Click this button to view this tutorial again.
